IFF Completes Divestiture of Flavor Specialty Ingredients Business
IFF (NYSE:IFF) today announced that it successfully completed the previously announced divestiture of its Flavor Specialty Ingredients (FSI) business to Exponent, a leading UK-based private equity firm, on August 1, 2023.
“The sale of our FSI business unit is another step in our journey to continuously maximize value,” said Frank Clyburn, IFF CEO. “Portfolio optimization is a central part of our ongoing strategy to improve growth and returns. This focus allows us to concentrate on our most attractive businesses and strengthen our capital structure by reducing outstanding debt. We’d like to thank our FSI colleagues for their demonstrated commitment to innovation, service and quality. We wish them the best for their new journey.”
Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statement” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “continue,” “see,” “will,” “would,” “towards,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our portfolio optimization and our growth. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.
© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801479685/en/
Contact information
Media Relations: Paula Heinkel 323.877.5339
Media.request@iff.com
Investor Relations: Michael Bender 212.708.7263
Investor.Relations@iff.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Clarity AI Honored in Fast Company Magazine’s 2023 “Brands That Matter” List4.10.2023 10:24:00 EEST | Press release
Clarity AI, the leading sustainability technology platform, has been named to Fast Company’s prestigious annual list of “Brands That Matter” in 2023. With this list, Fast Company, the world's leading business media brand, aims to get beyond “corporate vision statements and management talking points” and recognize brands that “clearly generate enthusiasm among their customers, offering a model of what other brands should be aiming for, and what a brand, at its best, can achieve.” Clarity AI was selected among more than 1,000 entries for its contribution to allowing “companies, investors, and more to ensure they’re investing sustainably by tracking metrics ranging from data on the climate impact to gender equality and diversity on the executive boards of prominent companies.” Additionally, Fast Company highlights Clarity AI’s role in “improving artificial technologies and understanding the multitude of benefits they can offer.” Rebeca Minguela, Founder & CEO of Clarity AI, said: “We're h
Uusi kysely: 66% suomalaisista työntekijöistä haluaisi kotona työskentelystä lain suojaaman oikeuden4.10.2023 10:00:00 EEST | Tiedote
Yhteistyötä tukevia ratkaisuja tarjoavan tekniikkayrityksen Owl Labsin hiljattain toteuttama kysely selvittää pohjoismaisten työntekijöiden asennoitumista etätyöhön. The State of Hybrid Work Report 2023 -tutkimukseen osallistui 2 000 vastaajaa Suomesta, Ruotsista, Norjasta ja Tanskasta. Raportista selviää, että peräti 66% suomalaisista työntekijöistä haluaisi etätyöstä tehtävän lain suojaaman oikeuden. Tämä kertoo joustavien työolojen kasvavasta suosiosta. Tutkimuksen mukaan 63% kaikista pohjoismaisista työntekijöistä on samaa mieltä oikeudesta etätyöhön. Tuki etätyölle laillisena oikeutena jakautuu eri Pohjoismaissa seuraavasti: 65% ruotsalaisista, 63% norjalaisista ja 57% tanskalaisista työntekijöistä tukee ajatusta. Owl Labsin toimitusjohtaja Frank Weishaupt sanoo: “Pohjoismaisten työntekijöiden yksimielisyys kotona työskentelystä lain suojaamana oikeutena kertoo muutoksista työntekijöiden asenteissa työympäristöään kohtaan. Se vahvistaa, miten tärkeänä työn ja vapaa-ajan välistä ta
ABN AMRO and Motive Partners form strategic partnership4.10.2023 09:30:00 EEST | Press release
The move demonstrates a joint commitment from two sizable financial technology investors to support continued innovation and growth in the evolving fintech landscape. Motive Ventures, the early-stage venture arm of Motive Partners, will manage the ABN AMRO Ventures Fund (AAV), consisting of 15 early-stage companies. In addition, ABN AMRO will become a significant investor in Motive-managed vehicles. With funding in the financial services industry declining by 70% between 2021 and 2022, and numerous venture capitalists reducing their investment programmes, Motive Partners and ABN AMRO are charting a new course. Their partnership unites two leading venture platforms, each with decades of fintech expertise and a dedication to innovation in both financial services and venture capital. Their goal is to strengthen the fintech sector and boost innovation by bringing Motive Partners’ ecosystem and experts to the AAV portfolio and ABN AMRO’s broader network. Motive Ventures’ portfolio consists
Desktop Health Announces that Flexcera™ Smile Ultra+ is now Available in Europe, Following Recent Class IIa MDR Certification by the European Union4.10.2023 09:00:00 EEST | Press release
Desktop Health™, the trusted health care brand of Desktop Metal (NYSE:DM), announced that its popular Flexcera™ Smile Ultra+ dental resin, for 3D printing permanent and temporary restorations, is now available for purchase in Europe following its successful certification as a Class IIa medical device under the European Union Medical Device Regulation (MDR). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231004075864/en/ Desktop Health's Flexcera™ Smile Ultra+ dental resin for 3D printing permanent and temporary restorations is now available for purchase in Europe following its successful certification as a Class IIa medical device under the European Union Medical Device Regulation (MDR). (Photo: Business Wire) Flexcera Smile Ultra+ delivers exceptional strength, life-like aesthetics, and the long-term performance expected from a permanent restoration material. Already an FDA 510(k) Class II cleared material, Flexcera Smile U
Velsera to Showcase Seven Bridges Bioinformatics Platform at BioTechX Europe4.10.2023 08:03:00 EEST | Press release
Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, is proud to announce its title sponsorship at BioTechX Europe in Basel, Switzerland, where it will showcase its industry-leading Seven Bridges bioinformatics platform. This conference is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. One of the keynote presentations, sponsored by Velsera, will be on the topic of “Digital Transformation of Early Research at Novo Nordisk and Leveraging AI/ML for Drug Discovery", featuring Asli Ismihan Ozen, head of research engineering, digital science and innovation at Novo Nordisk. She takes the stage at 9:20 am on Wednesday, Oct. 4. Additionally, Jack DiGiovanna, Velsera’s senior vice president of science strategy, will present on “Unleashing the Power of Neoantigens”, with an insightful look at solving complex problems through intero
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom